Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Shire launches adult ADHD initiatives

Shire launches adult ADHD initiatives

19th August 2009

Shire has announced the launch of two schemes that aim to reinforce its commitment to the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults.

The firm explained that ADHD is one of the most common psychiatric conditions in youngsters and adolescents and manifests itself as a persistent pattern of hyperactivity, inattention and/or impulsivity that is more frequent than that which is typically observed in people at a comparable stage of development.

Commenting on the launch of the schemes, Michael Yasick, senior vice-president of the ADHD business unit at Shire, said that the company is committed to providing information about the condition to people struggling with its symptoms, as well as healthcare professionals.

“These programmes demonstrate that adults with ADHD have Shire’s full attention,” he added.

Earlier this month, Shire announced that its board of directors has appointed Dr Michael Rosenblatt to its nomination and remuneration committees and that he will take up his position from October 27th.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.